Surfactant protein D enhances clearance of influenza A virus from the lung in vivo

Journal of Immunology

Volumn 167, Issue 10, 2001, Pages 5868-5873

  LeVine, A M ^a   Whitsett, J A ^a   Hartshorn, K L ^a   Crouch, E C ^a   Korfhagen, T R ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MYELOPEROXIDASE; RECOMBINANT PROTEIN; SURFACTANT PROTEIN D;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVITY; HOST RESISTANCE; INFLUENZA; INFLUENZA VIRUS A; LUNG CLEARANCE; MACROPHAGE; MOUSE; NEUTROPHIL; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; T LYMPHOCYTE; VIRUS RESISTANCE;

EID: 0035889906     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.167.10.5868     Document Type: Article

References (32)

1. Structures and functions associated with the group of mammalian lectins containing collagen-like sequences
2. Collectins: Pattern recognition molecules involved in first line host defense
3. Immunomodulatory functions of surfactant
4. Immunocytochemical localization of surfactant protein D (SP-D) in type II cells, Clara cells, and alveolar macrophages of rat lung
5. Lectin-mediated interactions of surfactant protein D with alveolar macrophages
6. Opsonic activities of surfactant proteins A and D in phagocytosis of Gram-negative bacteria by alveolar macrophages
7. Surfactant protein D stimulates phagocytosis of Pseudomonas aeruginosa by alveolar macrophages
8. Surfactant protein D binds to Mycobacterium tuberculosis bacilli and lipoarabinomannan via carbohydrate-lectin interactions resulting in reduced phagocytosis of the bacteria by macrophages
9. Surfactant protein D interacts with Pneumocystis carinii and mediates organism adherence to alveolar macrophages
10. Bovine and mouse serum 36 inhibitors of influenza A viruses are mannose-binding lectins
11. Human mannose-binding protein functions as an opsonin for influenza A viruses
12. Conglutinin acts as an opsonin for influenza A viruses
13. Interactions of surfactant protein A with influenza viruses: Binding and neutralization
14. Evidence for a protective role of pulmonary surfactant protein D (SP-D) against influenza A viruses
15. Influenza pneumonia
16. Surfactant proteins A and D in premature baboons with chronic lung injury (bronchopulmonary dysplasia)
17. Deficient hydrophilic lung surfactant proteins A and D with normal surfactant phospholipid molecular species in cystic fibrosis
18. Transfer of specific cytotoxic T lymphocytes protects mice inoculated with influenza virus
19. Protective mechanisms against pulmonary infection with influenza virus. I. Relative contribution of polymorphonuclear leukocytes and of alveolar macrophages to protection during the early phase of intranasal infection
20. Depressed monocyte chemotaxis during acute influenza infection
21. Effects of influenza A virus on human neutrophil calcium metabolism
22. Surfactant protein A, but not surfactant protein D, is an opsonin for influenza A virus phagocytosis by rat alveolar macrophages
23. Surfactant protein-D regulates surfactant phospholipid homeostasis in vivo
24. Enhanced anti-influenza activity of a surfactant protein D and serum conglutinin fusion protein
25. Interactions of recombinant human pulmonary surfactant protein D and SP-D multimers with influenza A
26. Distinct effects of surfactant protein A or D deficiency during bacterial infection in the lung
27. Mechanisms of anti-influenza activity of surfactant proteins A and D: Comparison with serum collectin
28. Increased metalloproteinase activity, oxidant production, and emphysema in surfactant protein D gene-inactivated mice
29. A kinetic study of immune mediators in the lungs of mice infected with influenza A virus
30. Recombinant rat surfactant-associated protein D inhibits human T lymphocyte proliferation and IL-2 production
31. Influenza A virus and the neutrophil: A model of natural immunity
32. Influenza A virus-induced polymorphonuclear leukocyte dysfunction in the pathogenesis of experimental pneumococcal otitis media